These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30156292)

  • 1. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
    Ohlsson S; Diedrich B; Uhlin M; Sandgren P
    Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
    Sandgren P; Diedrich B
    Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system.
    Johnson L; Loh YS; Kwok M; Marks DC
    Transfus Med; 2013 Apr; 23(2):121-9. PubMed ID: 23480103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.
    Reikvam H; Marschner S; Apelseth TO; Goodrich R; Hervig T
    Blood Transfus; 2010 Jul; 8(3):186-92. PubMed ID: 20671879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
    Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
    Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and pathogen inactivation of double dose buffy coat platelet products using the INTERCEPT blood system.
    Abedi MR; Doverud AC
    J Vis Exp; 2012 Dec; (70):e4414. PubMed ID: 23242463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
    Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
    Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.
    Plaza EM; Lozano ML; Guiu IS; Egea JM; Vicente V; De Terán LC; Rivera J
    Blood Transfus; 2012 Oct; 10(4):480-9. PubMed ID: 22682335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
    Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
    Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects.
    Rosskopf K; Helmberg W; Schlenke P
    Transfusion; 2020 Sep; 60(9):2058-2066. PubMed ID: 32619068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreservation of buffy coat-derived platelet concentrates photochemically treated with amotosalen and UVA light.
    Meinke S; Wikman A; Gryfelt G; Hultenby K; Uhlin M; Höglund P; Sandgren P
    Transfusion; 2018 Nov; 58(11):2657-2668. PubMed ID: 30281156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
    Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit.
    Sandgren P; Saeed K
    Blood Transfus; 2011 Apr; 9(2):182-8. PubMed ID: 21084001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
    Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
    Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
    Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
    Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation.
    Picker SM; Speer R; Gathof BS
    Transfusion; 2004 Mar; 44(3):320-9. PubMed ID: 14996187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.
    Ostrowski SR; Bochsen L; Salado-Jimena JA; Ullum H; Reynaerts I; Goodrich RP; Johansson PI
    Transfusion; 2010 Oct; 50(10):2210-9. PubMed ID: 20456708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters.
    Johnson L; Cameron M; Waters L; Padula MP; Marks DC
    Vox Sang; 2019 Jan; 114(1):47-56. PubMed ID: 30499111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats.
    van Rhenen DJ; Vermeij J; Mayaudon V; Hind C; Lin L; Corash L
    Vox Sang; 2000; 79(4):206-14. PubMed ID: 11155071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.